Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Neoadjuvant chemotherapy evaluated in stage III breast cancer
September 15th, 2005
Scientists evaluated the effect of neoadjuvant chemotherapy prior to surgery in stage III breast cancer patients. According to recent research from the United States, "Neoadjuvant chemotherapy in advanced breast cancer can potentially downstage disease prior to definitive surgery. In this study, a doxorubicin-based neoadjuvant regimen was administered to stage III breast cancer patients to assess 1) primary tumor response, 2) tumor involvement of resection margins, and 3) predictive value in cancer outcome." "Eighty-two patients with stage IIIA and IIIB breast cancer diagnosed between 1990 and 2003 were studied. All patients received similar...
Source: Women's Health Weekly (2005-09-15)
|
